PURPOSE: I METHODS AND MATERIALS: An IRB-approved single-institution retrospective chart review was performed from 2011 to 2019 for patients with posterior UM treated with brachytherapy. We collected demographics, pretreatment tumor characteristics and posttreatment complications. Univariate analysis (UVA) and multivariate analysis (MVA) were performed using logistic regression model. Hazard ratios (HR) and corresponding p-values were reported. All tests were two-sided; statistical significance was considered when p\u3c0.05. RESULTS: Two hundred and fifty eight patients were evaluated. Median follow-up was 33.50 months (range 3.02-97.31). 178 patients (69.0%) had RTT. 131 patients (50.8%) developed RM. Fifty-six patients (21.7%) developed R...
PURPOSE: To analyze the long-term results of eye retention after conservative treatment of uveal mel...
Purpose: To report ocular findings in eyes with radiation retinopathy and visual acuity (VA) results...
Treatment of choroidal melanoma with radiation plaque brachytherapy (Iodine, (I125) avoids enucleati...
PURPOSE: I METHODS AND MATERIALS: An IRB-approved single-institution retrospective chart review was ...
<div><p>Background</p><p>To report on radiation-related side effects and complications after rutheni...
Purpose: To investigate how treatment complications are related to dosimetric parameters after ruthe...
PURPOSE: The purpose of this study is to report on treatment outcomes for medium-sized choroidal mel...
To report on radiation-related side effects and complications after ruthenium-106 plaque brachythera...
Purpose : The aim of this study was to report on results of uveal melanoma treatment with ruthenium-...
Purpose : The Collaborative Ocular Melanoma Study (COMS) established modern treatment recommendation...
Purpose : To develop a predictive model and nomogram for maculopathy occurrence at 3 years after 10...
International audienceRuthenium-106 (Ru-106) brachytherapy is an established modality for eye-preser...
PURPOSE: To assess the role of vitreoretinal surgery in maximizing treatment outcome following compl...
PURPOSE: To evaluate low- vs high-dose plaque brachytherapy for juxtapapillary choroidal melanoma. D...
Purpose: To report the results of a patient’s tailored therapeutic approach using a second course of...
PURPOSE: To analyze the long-term results of eye retention after conservative treatment of uveal mel...
Purpose: To report ocular findings in eyes with radiation retinopathy and visual acuity (VA) results...
Treatment of choroidal melanoma with radiation plaque brachytherapy (Iodine, (I125) avoids enucleati...
PURPOSE: I METHODS AND MATERIALS: An IRB-approved single-institution retrospective chart review was ...
<div><p>Background</p><p>To report on radiation-related side effects and complications after rutheni...
Purpose: To investigate how treatment complications are related to dosimetric parameters after ruthe...
PURPOSE: The purpose of this study is to report on treatment outcomes for medium-sized choroidal mel...
To report on radiation-related side effects and complications after ruthenium-106 plaque brachythera...
Purpose : The aim of this study was to report on results of uveal melanoma treatment with ruthenium-...
Purpose : The Collaborative Ocular Melanoma Study (COMS) established modern treatment recommendation...
Purpose : To develop a predictive model and nomogram for maculopathy occurrence at 3 years after 10...
International audienceRuthenium-106 (Ru-106) brachytherapy is an established modality for eye-preser...
PURPOSE: To assess the role of vitreoretinal surgery in maximizing treatment outcome following compl...
PURPOSE: To evaluate low- vs high-dose plaque brachytherapy for juxtapapillary choroidal melanoma. D...
Purpose: To report the results of a patient’s tailored therapeutic approach using a second course of...
PURPOSE: To analyze the long-term results of eye retention after conservative treatment of uveal mel...
Purpose: To report ocular findings in eyes with radiation retinopathy and visual acuity (VA) results...
Treatment of choroidal melanoma with radiation plaque brachytherapy (Iodine, (I125) avoids enucleati...